Skip to main content
Top
Published in: Diabetologia 2/2008

01-02-2008 | Article

Predictors of cognitive impairment and dementia in older people with diabetes

Authors: D. G. Bruce, W. A. Davis, G. P. Casey, S. E. Starkstein, R. M. Clarnette, J. K. Foster, O. P. Almeida, T. M. E. Davis

Published in: Diabetologia | Issue 2/2008

Login to get access

Abstract

Aims/hypothesis

Diabetes is associated with an increased risk of dementia but the reasons for this association are unclear because there are many potential mechanisms. We explored the relative contribution of diabetes-related variables as predictors of dementia in older individuals with diabetes.

Methods

Survivors, aged ≥70 or more, were recruited from an existing observational cohort study 7.6 ± 1.0 years after baseline, when they underwent a comprehensive assessment of diabetes, complications and cardiovascular risk factors. Dementia, probable Alzheimer’s disease and cognitive impairment without dementia were diagnosed clinically. Logistic regression modelling determined independent predictors of cognitive diagnoses.

Results

Of 302 participants, aged 75.7 ± 4.6 years, 28 (9.3%) had dementia (16 with probable Alzheimer’s disease) and 60 (19.9%) had cognitive impairment without dementia. The major independent longitudinal predictors of dementia were older age (per decade; odds ratio 4.0, 95% CI 1.59–10.10), diabetes duration (for each 5 years; odds ratio 1.69, 95% CI 1.24–2.32), peripheral arterial disease (odds ratio 5.35, 95% CI 2.08–13.72) and exercise (which was protective; odds ratio 0.26, 95% CI 0.09–0.73). For Alzheimer’s disease, diabetes duration was an independent predictor in addition to age and diastolic blood pressure. The results of the cross-sectional analyses were similar with respect to diabetes duration and peripheral arterial disease.

Conclusions/interpretation

Peripheral arterial disease is a strong independent risk factor for dementia in diabetes. After adjustment for a wide range of potential risk factors, diabetes duration remains independently associated with dementia and probable Alzheimer’s disease, indicating that factors not measured in this study may be important in the pathogenesis of dementia in diabetes.
Literature
1.
go back to reference Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef Cukierman T, Gerstein HC, Williamson JD (2005) Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies. Diabetologia 48:2460–2469PubMedCrossRef
2.
go back to reference Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169–175PubMedCrossRef Allen KV, Frier BM, Strachan MW (2004) The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol 490:169–175PubMedCrossRef
3.
go back to reference Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type 2 diabetes mellitus associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438–445PubMedCrossRef Strachan MW, Deary IJ, Ewing FM, Frier BM (1997) Is type 2 diabetes mellitus associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20:438–445PubMedCrossRef
4.
go back to reference De la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33:1152–1162PubMedCrossRef De la Torre JC (2002) Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33:1152–1162PubMedCrossRef
5.
go back to reference Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, ApoE gene, and the risk for dementia and related pathologies: the Honolulu–Asia Aging Study. Diabetes 51:1256–1262PubMedCrossRef Peila R, Rodriguez BL, Launer LJ (2002) Type 2 diabetes, ApoE gene, and the risk for dementia and related pathologies: the Honolulu–Asia Aging Study. Diabetes 51:1256–1262PubMedCrossRef
6.
go back to reference Newman AB, Fitzpatrick AL, Lopez O et al (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53:1101–1107PubMedCrossRef Newman AB, Fitzpatrick AL, Lopez O et al (2005) Dementia and Alzheimer’s disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. J Am Geriatr Soc 53:1101–1107PubMedCrossRef
7.
go back to reference Van Oijen M, de Jong FJ, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MMB (2007) Atherosclerosis and risk for dementia. Ann Neurol 61:404–410CrossRef Van Oijen M, de Jong FJ, Witteman JCM, Hofman A, Koudstaal PJ, Breteler MMB (2007) Atherosclerosis and risk for dementia. Ann Neurol 61:404–410CrossRef
8.
go back to reference Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and the risk of dementia in the Kungsholmen project: a six year follow-up study. Neurology 63:1181–1186PubMed Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L (2004) Diabetes mellitus and the risk of dementia in the Kungsholmen project: a six year follow-up study. Neurology 63:1181–1186PubMed
9.
go back to reference Whitmer RA, Sidney S, Selby J, Clairborne Johnston S, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277–281PubMed Whitmer RA, Sidney S, Selby J, Clairborne Johnston S, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64:277–281PubMed
10.
go back to reference Cole AR, Astell A, Green C, Sutherland C (2007) Molecular connections between dementia and diabetes. Neurosci Biobehav Rev 31:1046–1063.PubMedCrossRef Cole AR, Astell A, Green C, Sutherland C (2007) Molecular connections between dementia and diabetes. Neurosci Biobehav Rev 31:1046–1063.PubMedCrossRef
11.
go back to reference Sato T, Shimogaito N, Wu X, Kikuchi S, Yamagishi S, Takeuchi M (2006) Toxic advanced glycation end products theory in Alzheimer’s disease. Am J Alzheimers Dis Other Dement 21:197–208CrossRef Sato T, Shimogaito N, Wu X, Kikuchi S, Yamagishi S, Takeuchi M (2006) Toxic advanced glycation end products theory in Alzheimer’s disease. Am J Alzheimers Dis Other Dement 21:197–208CrossRef
12.
go back to reference Carro E, Torres-Aleman I (2004) The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s disease. Eur J Pharmacol 490:127–133PubMedCrossRef Carro E, Torres-Aleman I (2004) The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer’s disease. Eur J Pharmacol 490:127–133PubMedCrossRef
13.
go back to reference Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663PubMed Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K (2004) Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658–663PubMed
14.
go back to reference Ott A, Stolk RP, van Harskamp F, Pols HAP, Hoffman A, Breteler M (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937–1942PubMed Ott A, Stolk RP, van Harskamp F, Pols HAP, Hoffman A, Breteler M (1999) Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53:1937–1942PubMed
15.
go back to reference MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83PubMedCrossRef MacKnight C, Rockwood K, Awalt E, McDowell I (2002) Diabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement Geriatr Cogn Disord 14:77–83PubMedCrossRef
16.
go back to reference Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 160:174–180PubMedCrossRef Gregg EW, Yaffe K, Cauley JA et al (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 160:174–180PubMedCrossRef
17.
go back to reference Bruce DG, Davis WA, Davis TME (2000) Glycemic control in older diabetic patients in the Fremantle Diabetes Study. J Am Geriatr Soc 48:1449–1453PubMed Bruce DG, Davis WA, Davis TME (2000) Glycemic control in older diabetic patients in the Fremantle Diabetes Study. J Am Geriatr Soc 48:1449–1453PubMed
18.
go back to reference Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674PubMedCrossRef Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR (2000) Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabetic Med 17:667–674PubMedCrossRef
19.
go back to reference Bruce DG, Casey G, Davis WA et al (2006) Vascular depression in older people with diabetes. Diabetologia 49:2828–2836PubMedCrossRef Bruce DG, Casey G, Davis WA et al (2006) Vascular depression in older people with diabetes. Diabetologia 49:2828–2836PubMedCrossRef
20.
go back to reference Davis TME, Davis W, Mulder JW, Fortune P, Bruce DG (2004) Silent myocardial infarction and its prognosis in a community-based cohort of diabetic patients: the Fremantle Diabetes Study. Diabetologia 47:395–399PubMedCrossRef Davis TME, Davis W, Mulder JW, Fortune P, Bruce DG (2004) Silent myocardial infarction and its prognosis in a community-based cohort of diabetic patients: the Fremantle Diabetes Study. Diabetologia 47:395–399PubMedCrossRef
21.
go back to reference Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289PubMedCrossRef Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289PubMedCrossRef
22.
go back to reference Davis WA, Knuiman MW, Hendrie D, Davis TME (2005) Determinants of diabetes-attributable non-blood glucose-lowering medication costs for type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 28:329–336PubMedCrossRef Davis WA, Knuiman MW, Hendrie D, Davis TME (2005) Determinants of diabetes-attributable non-blood glucose-lowering medication costs for type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 28:329–336PubMedCrossRef
23.
go back to reference Norman PE, Davis WA, Bruce DG, Davis TM (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes. Diabetes Care 29:575–580PubMedCrossRef Norman PE, Davis WA, Bruce DG, Davis TM (2006) Peripheral arterial disease and risk of cardiac death in type 2 diabetes. Diabetes Care 29:575–580PubMedCrossRef
24.
go back to reference Bruce DG, Starkstein SE, Davis WA, Davis TME (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef Bruce DG, Starkstein SE, Davis WA, Davis TME (2005) A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 48:2532–2539PubMedCrossRef
25.
go back to reference Folstein M, Folstein S, McHugh PR (1975) Mini-mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef Folstein M, Folstein S, McHugh PR (1975) Mini-mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198PubMedCrossRef
26.
go back to reference Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24:145–153PubMedCrossRef Jorm AF (1994) A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24:145–153PubMedCrossRef
27.
go back to reference Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMed Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412–2414PubMed
28.
go back to reference McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group. Neurology 34:939–943PubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group. Neurology 34:939–943PubMed
29.
go back to reference Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH (1993) Vascular dementia. Diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43:250–260PubMed Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH (1993) Vascular dementia. Diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 43:250–260PubMed
30.
go back to reference McKeith IG, Galasko D, Kosaka K, Perry E.K, Dickson DW, Hansen LA (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology 47:1113–1124PubMed McKeith IG, Galasko D, Kosaka K, Perry E.K, Dickson DW, Hansen LA (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB international workshop. Neurology 47:1113–1124PubMed
31.
go back to reference Stehouwer CDA, Gall M, Twisk JWR, Knudsen E, Emeis JJ, Parving H (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated and independently associated with risk of death. Diabetes 51:1157–1165PubMedCrossRef Stehouwer CDA, Gall M, Twisk JWR, Knudsen E, Emeis JJ, Parving H (2002) Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated and independently associated with risk of death. Diabetes 51:1157–1165PubMedCrossRef
32.
go back to reference Selvin E, Erlinger T (2004) Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey 1999–2000. Circulation 110:738–743PubMedCrossRef Selvin E, Erlinger T (2004) Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey 1999–2000. Circulation 110:738–743PubMedCrossRef
33.
go back to reference Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AS (2006) HbA1c and peripheral arterial disease in diabetes. Diabetes Care 2:877–882CrossRef Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AS (2006) HbA1c and peripheral arterial disease in diabetes. Diabetes Care 2:877–882CrossRef
34.
go back to reference Akomolafe A, Beiser A, Meigs J et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555, 2006PubMedCrossRef Akomolafe A, Beiser A, Meigs J et al (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol 63:1551–1555, 2006PubMedCrossRef
35.
go back to reference Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes 56:211–216PubMedCrossRef Xu W, Qiu C, Winblad B, Fratiglioni L (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer’s disease. Diabetes 56:211–216PubMedCrossRef
36.
go back to reference Jorm AF, Jolley D (1998) The incidence of dementia: a meta-analysis. Neurology 51:728–733PubMed Jorm AF, Jolley D (1998) The incidence of dementia: a meta-analysis. Neurology 51:728–733PubMed
37.
go back to reference Birkenhager WH, Staessen JA (2006) Cognitive function in essential hypertension. Prog Cardiovasc Dis 49:1–10PubMedCrossRef Birkenhager WH, Staessen JA (2006) Cognitive function in essential hypertension. Prog Cardiovasc Dis 49:1–10PubMedCrossRef
38.
go back to reference Larson EB, Wang L, Bowen JD et al (2006) Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144:73–81PubMed Larson EB, Wang L, Bowen JD et al (2006) Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144:73–81PubMed
39.
go back to reference Fabrigoule C, Letenneur L, Dartigues JF, Arrouk M, Commenges D, Barberger-Gateau P (1995) Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 43:485–490PubMed Fabrigoule C, Letenneur L, Dartigues JF, Arrouk M, Commenges D, Barberger-Gateau P (1995) Social and leisure activities and risk of dementia: a prospective longitudinal study. J Am Geriatr Soc 43:485–490PubMed
41.
go back to reference Tuokko H, Frerichs R, Graham J et al (2003) Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 60:577–582PubMedCrossRef Tuokko H, Frerichs R, Graham J et al (2003) Five-year follow-up of cognitive impairment with no dementia. Arch Neurol 60:577–582PubMedCrossRef
42.
go back to reference Van den Berg E, Kessels RPC, de Haan EHF, Kappele LJ, Biessels GJ (2005) Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND. J Neurol Neurosurg Psychiatry 76:1466–1467PubMedCrossRef Van den Berg E, Kessels RPC, de Haan EHF, Kappele LJ, Biessels GJ (2005) Mild impairments in cognition in patients with type 2 diabetes mellitus: the use of the concepts MCI and CIND. J Neurol Neurosurg Psychiatry 76:1466–1467PubMedCrossRef
43.
go back to reference DeCarli C, Mungas D, Harvey D et al (2004) Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 63:220–227PubMed DeCarli C, Mungas D, Harvey D et al (2004) Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 63:220–227PubMed
Metadata
Title
Predictors of cognitive impairment and dementia in older people with diabetes
Authors
D. G. Bruce
W. A. Davis
G. P. Casey
S. E. Starkstein
R. M. Clarnette
J. K. Foster
O. P. Almeida
T. M. E. Davis
Publication date
01-02-2008
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2008
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-007-0894-7

Other articles of this Issue 2/2008

Diabetologia 2/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.